PDCD1 and autoimmune glomerulonephritis: Studies in experimental autoimmune glomerulonephritis have shown that blockade of PD-1/PD-1L interaction aggravates glomerular injury and cellular infiltration (64) and that activation of PD-1 using a PD-L1 fusion protein leads to a reduction in disease severity (30).